InvestSMART

Anatara Lifesciences Ltd (ASX: ANR) - Announcements

- Current share price for ANR : $0.009

ASX company news and announcements for Anatara Lifesciences Ltd (ANR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anatara Lifesciences Ltd (ANR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anatara Lifesciences Ltd (ANR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anatara Lifesciences Ltd (ANR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2025 4:36PM $0.005 $0.009 risen by 80%
$3 Phase II GaRP-IBS Trial Headline Analysis of Results 17 Apr 2025 11:31AM $0.006 $0.009 risen by 50%
$3 Phase II GaRP-IBS Trial & Anti-Obesity Project Updates 10 Mar 2025 9:23AM $0.039 $0.009 fallen by 76.92%
$3 Final Director's Interest Notice 7 Mar 2025 12:33PM $0.039 $0.009 fallen by 76.92%
$3 Initial Director's Interest Notice 7 Mar 2025 12:33PM $0.039 $0.009 fallen by 76.92%
$3 Trading Halt 6 Mar 2025 9:02AM $0.039 $0.009 fallen by 76.92%
$3 Board Changes 28 Feb 2025 4:42PM $0.042 $0.009 fallen by 78.57%
$3 Appendix 4D & Half Year Report 31 December 2024 25 Feb 2025 10:58AM $0.057 $0.009 fallen by 84.21%
$3 Phase II GaRP-IBS Trial & Anti-Obesity Project Updates 20 Feb 2025 11:56AM $0.042 $0.009 fallen by 78.57%
$3 Australian Patent Granted for GaRP Product 28 Jan 2025 10:45AM $0.052 $0.009 fallen by 82.69%
$3 Quarterly Activities/Appendix 4C Cash Flow Report 15 Jan 2025 8:24AM $0.057 $0.009 fallen by 84.21%
$3 Notification regarding unquoted securities - ANR 24 Dec 2024 11:42AM $0.045 $0.009 fallen by 80%
$3 Change of Director's Interest Notice 24 Dec 2024 10:54AM $0.050 $0.009 fallen by 82%
$3 Addendum to Company Presentation released on 2 December 2024 23 Dec 2024 2:56PM $0.051 $0.009 fallen by 82.18%
$3 Application for quotation of securities - ANR 23 Dec 2024 10:46AM $0.051 $0.009 fallen by 82.18%
$3 Share Purchase Plan Results 20 Dec 2024 12:23PM $0.051 $0.009 fallen by 82.18%
$3 GaRP-IBS Clinical Trial Update 13 Dec 2024 8:24AM $0.046 $0.009 fallen by 80.43%
$3 GaRP-IBS Clinical Trial Update 4 Dec 2024 10:02AM $0.057 $0.009 fallen by 84.21%
$3 Webinar and Q&A 2 Dec 2024 10:39AM $0.057 $0.009 fallen by 84.21%
$3 Investor Presentation 2 Dec 2024 10:38AM $0.057 $0.009 fallen by 84.21%
$3 Company Secretary Appointment/Resignation 29 Nov 2024 4:00PM $0.057 $0.009 fallen by 84.21%
$3 Share Purchase Plan Shareholder Letter 27 Nov 2024 8:31AM $0.058 $0.009 fallen by 84.48%
$3 Share Purchase Plan Offer Booklet 27 Nov 2024 8:28AM $0.058 $0.009 fallen by 84.48%
$3 Cleansing Notice 27 Nov 2024 8:20AM $0.058 $0.009 fallen by 84.48%
$3 Change in substantial holding from Tiga Trading Pty Ltd 22 Nov 2024 5:09PM $0.058 $0.009 fallen by 84.48%

51 - 75 of 533 results

Page 3 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.